Want to join the conversation?
Financial services company $AMP said that 1Q16 revenue was down 4% to $2.8Bil and EPS was relative flat at $2.17. The company's ROE excluding AOCI is strong at 24.2%, up 110 BP from 1Q15. During 1Q16, the company said that it nearly doubled the number of shares it repurchased from a year ago to 5.1MM.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.